Lex M. Cowsert

CytoGenix, Inc. focuses on development and commercialization of its proprietary technology for identify and silencing disease causing genes and expressing proteins for applications. The company was founded on February 10, 1995 and is headquartered in Houston, TX.

Automated Cell, Inc. provides drug discovery services to the pharmaceutical and biotechnology markets. The company uses automated cell biology tools for improving the productivity of therapeutic development in cell therapy & drug discovery. It focuses on the development of monoclonal antibody therapeutics for the treatment of cancer. The company was founded by Raymond K. Houck & Dr. Paul DiMilla in 1998 and is headquartered in Pittsburgh, PA.

VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions.

HoustonPharma, Inc. develops pharmaceutical products and technologies. It develops oncolytic virus technologies for the treatment of cancer, including ovarian cancer, glioblastoma, and multiple myeloma. The company is headquartered in Malvern, PA.